Navigation Links
ISPE Named as a Source in FDA Strategic Plan for Preventing and Mitigating Drug Shortages
Date:10/31/2013

TAMPA, Fla., Oct. 31, 2013 /PRNewswire-USNewswire/ -- ISPE's report on its 2013 Drug Shortages Survey was cited twice in the Strategic Plan for Preventing and Mitigating Drug Shortages released today by the US Food and Drug Administration (FDA). The plan also formalized the FDA's commitment to engaging with ISPE "to analyze data from a recent global survey ISPE conducted on the technical, scientific, manufacturing, quality, and compliance issues that have resulted in drug shortages."  Dr. Douglas Throckmorton, deputy director of the FDA's Center for Drug Evaluation and Research (CDER), said later on a teleconference with stakeholders, "We are looking forward to continuing to work with ISPE."

(Logo: http://photos.prnewswire.com/prnh/20120912/DC73253LOGO)  

Published in June 2013, the report on ISPE's Drug Shortages Survey is available at www.ISPE.org/Drug-Shortages/2013JuneReport. The comprehensive global survey revealed no single technical or manufacturing cause for drug shortages. Instead, initial data analysis showed:

  • Issues within the quality systems of manufacturing can lead to drug shortages.
  • Companies that have successfully avoided drug shortages focus on strong quality systems, and the involvement of company leadership is notable in those companies that avoid shortages. 
  • Improved regulatory interaction can mitigate the likelihood of a shortage.

"We are pleased that ISPE's work has been helpful to the FDA in its consideration of the challenges of addressing drug shortages," says Nancy S. Berg, President and CEO of ISPE. "The survey revealed many new opportunities for ISPE to facilitate dialogue throughout the industry, advancing our collective understanding of the causes of drug shortages and leading to process improvements that may mitigate or avoid them.  As a neutral organization focused on product quality and patient safety, ISPE is uniquely positioned to play this role."

Since the report's initial release the ISPE Drug Shortages Task Force has continued to examine the data and further investigate key issues. These findings will be reported Monday, 4 November at ISPE's Annual Meeting in Washington, DC. The Society will also release its 2014 schedule of events related to Drug Shortages in conjunction with the meeting.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is the world's largest not-for-profit association serving its Members through leading scientific, technical and regulatory advancement throughout the pharmaceutical lifecycle. The 20,000 Members of ISPE are building solutions in the development and manufacture of safe and effective pharmaceutical and biologic medicines and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Tampa, Florida, USA. Visit www.ISPE.org for more information.  To learn more about ISPE's Annual Meeting visit www.ISPE.org/2013annualmeeting

For more information contact:
Danielle Hould
ISPE Membership Marketing Communications Manager
Tel: +1-813-960-2105, ext. 277
Email: dhould@ispe.org
www.ISPE.org  


'/>"/>
SOURCE ISPE
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Dr. Prem Reddy Named Among Most Influential Physician Executives in Nation
2. Bayer Employees Named Rising Stars by Healthcare Businesswomens Association
3. Remedy Informatics Named "Cool Vendor" in Life Sciences by Leading Technology Analyst Firm
4. Dr. Phillip Chan Named Finalist for Ernst & Young Entrepreneur of the Year® 2012 Award in New Jersey
5. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
6. StreamVenue Healthcare CEO Named Peoples Choice Winner
7. Masimo CEO Joe Kiani Named Ernst & Young Entrepreneur of the Year
8. Prime Therapeutics Named a Top Workplace by the Minneapolis Star Tribune
9. WellTok Named Colorado Company to Watch for 2012
10. 3 Pediatric Centers that Offer SynCardia Total Artificial Heart Named in Top 10 for "Best Childrens Hospitals"
11. Nonin Medical Named Platinum Partner by Tri-anim Health Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... -- AOTI Inc. announced today that its fully owned USA ... New York City Office in Yonkers, New York ... Oxygen (TWO 2 ) homecare therapy. This new East Coast location ... (ACHC) under the company,s DMEPOS accreditation for Home/Durable Medical Equipment Services. ... Advanced Oxygen Therapy Inc. ...
(Date:8/10/2017)... -- Physical Rehabilitation Network (PRN), acquired the long-standing outpatient rehabilitation clinic, ... . The reputable clinic will continue to be co-owned and ... staff of four clinicians. Lipkin received his doctorate in physical ... years of experience with a strong background in manual therapy. ... 10th PRN clinic in and around the Denver ...
(Date:8/7/2017)... 7, 2017 Insightin Health, provider of ... and engagement, announced the selection of Michael ... Development, effective as of February 2017. In this role, ... strategy for our clients. Wood brings with him ... and business analytics within the healthcare industry. Wood ...
Breaking Medicine Technology:
(Date:8/23/2017)... (PRWEB) , ... August 23, 2017 , ... ... of the Golden Bridge Awards® - for Risk Management Solution Innovations and Security ... Halo™ online platform released in 2017 and its DHS SAFETY Act-designated enterprise ...
(Date:8/22/2017)... Alpharetta, GA (PRWEB) , ... August 22, 2017 , ... ... across America, has awarded Zyclear Migraine Relief with the 2017 Women’s Choice Award. The ... as studies show that 3 out of 4 migraine sufferers are women. In a ...
(Date:8/22/2017)... ... August 22, 2017 , ... Each of the past six years, Lightning Labels has sent ... these labels and stickers, demonstrating the variety and creativity of their designs. Submissions this year ... came in. Now, it's time to announce the winners of the sixth annual Photo Contest, ...
(Date:8/22/2017)... ... August 22, 2017 , ... “To Walk Away”: a ... B17 bomber named Edward Koontz. “To Walk Away” is the creation of published author, ... published over two hundred manuscripts in chemistry and religion, as well as four novels. ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... “Glimpses Of ... understanding of the world. “Glimpses Of Light” is the creation of published author, J.M. ... life in search of answers to life’s perplexing mysteries. , Shepherd shares, “Love is ...
Breaking Medicine News(10 mins):